Clinical features of 78 adults with 22q11 deletion syndrome

22q11 Deletion Syndrome (22q11DS) is a common microdeletion syndrome with multisystem expression. Phenotypic features vary with age, ascertainment, and assessment. We systematically assessed 78 adults (36 M, 42 F; mean age 31.5, SD 10.5 years) with a 22q11.2 deletion ascertained through an adult con...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of medical genetics. Part A Vol. 138A; no. 4; pp. 307 - 313
Main Authors Bassett, Anne S., Chow, Eva W.C., Husted, Janice, Weksberg, Rosanna, Caluseriu, Oana, Webb, Gary D., Gatzoulis, Michael A.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.11.2005
Subjects
Online AccessGet full text
ISSN1552-4825
1552-4833
1552-4833
DOI10.1002/ajmg.a.30984

Cover

More Information
Summary:22q11 Deletion Syndrome (22q11DS) is a common microdeletion syndrome with multisystem expression. Phenotypic features vary with age, ascertainment, and assessment. We systematically assessed 78 adults (36 M, 42 F; mean age 31.5, SD 10.5 years) with a 22q11.2 deletion ascertained through an adult congenital cardiac clinic (n = 35), psychiatric‐related sources (n = 39), or as affected parents of subjects (n = 4). We recorded the lifetime prevalence of features requiring attention, with 95% confidence intervals (CI) not overlapping zero. Subtle learning difficulties, hypernasality and facial gestalt were not included. We investigated ascertainment effects using non‐overlapping subgroups ascertained with tetralogy of Fallot (n = 31) or schizophrenia (n = 31). Forty‐three features met inclusion criteria and were present in 5% or more patients, including several of later onset (e.g., hypothyroidism, cholelithiasis). Number of features per patient (median 9, range 3–22) correlated with hospitalizations (P = 0.0002) and, when congenital features were excluded, with age (P = 0.02). Adjusting for ascertainment, 25.8% (95% CI, 9.5–42.1%) of patients had cardiac anomalies and 22.6% (95% CI, 7.0–38.2%) had schizophrenia. Ascertainment subgroups were otherwise similar in median number and prevalence of features. Non‐characteristic features are common in 22q11DS. Adjusting for ascertainment effects is important. Many treatable conditions may be anticipated and features may accumulate over time. The results have implications for clinical assessment and management, genetic counseling and research into pathophysiological mechanisms. © 2005 Wiley‐Liss, Inc.
Bibliography:istex:F5C91A2F42DDF942A706FF70E3A6F9730C174D73
ark:/67375/WNG-82S08D56-5
ArticleID:AJMG30984
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Michael A. Gatzoulis’s present address is Adult Congenital Heart Program, Royal Brompton Hospital, London, UK.
Gary D. Webb’s present address is Adult Congenital Heart Center, University of Pennsylvania, Philadelphia.
ISSN:1552-4825
1552-4833
1552-4833
DOI:10.1002/ajmg.a.30984